Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Stem cells enhance mitochondrial function in experimental Huntington's disease.

Stem cells (Dayton, Ohio)·2026

Same author

Apolipoprotein A1 reduces blood-spinal cord barrier leakage, improves astrocytic coverage, and enhances motor neuron survival to restore the neurovascular unit in ALS mice.

Frontiers in aging neuroscience·2026

Same author

Altered Lipid Metabolism in CNS Demyelination and Remyelination Are Key Elements Driving Progressive MS.

International journal of molecular sciences·2025

Same author

Ischemic Penumbra Protection: Beyond Brains or Not.

MedComm·2025

Same author

Stem Cells Run Like Clockwork for Stroke Therapeutics.

Stem cell reviews and reports·2025

Same author

MIF functional polymorphisms are associated with acute GVHD progression and steroid-refractoriness.

Frontiers in immunology·2025

Same journal

Holter parameters score predicts prognosis in patients with acute ischemic stroke: A prospective cohort study.

Brain circulation·2026

Same journal

Progress on the mechanism of pathological injury secondary to venous stroke and their therapeutic strategies: A narrative review.

Brain circulation·2026

Same journal

Remote ischemic conditioning for cerebral ischemia in patients with Takayasu arteritis (TARIC-1): Study protocol.

Brain circulation·2026

Same journal

Moyamoya syndrome in a patient with pathogenic heterozygous variant in the <i>SETD5</i> gene: A case report.

Brain circulation·2026

Same journal

Antiplatelet therapy after intravenous thrombolysis in acute ischemic stroke: No longer one-size-fits-all.

Brain circulation·2026

Same journal

Effect of cerebral oxygen saturation on outcomes of patients with ruptured intracranial aneurysms undergoing endovascular embolization: A prospective observational study.

Brain circulation·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Nov 3, 2025

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

Major histocompatibility complex Class II-based therapy for stroke.

Bella M Gonzales-Portillo¹, Jea-Young Lee², Arthur A Vandenbark^3,4,5

¹Department of Biomedical Engineering, Northwestern University, Evanston, IL, USA.

Brain Circulation

|June 4, 2021

Summary

This summary is machine-generated.

Major histocompatibility complex (MHC) Class II constructs, like DRmQ, show promise for treating ischemic stroke. This approach reduces inflammation and improves outcomes by targeting secondary cell death pathways.

Keywords:

Cell death DRmQ cytokines mesenchymal stem cell mitochondrial transfer stem cell therapy stroke therapy

More Related Videos

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Published on: May 24, 2021

Related Experiment Videos

Last Updated: Nov 3, 2025

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research

Published on: December 15, 2023

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery

Published on: May 24, 2021

Area of Science:

Neuroscience
Immunology
Pharmacology

Background:

Ischemic stroke causes significant secondary cell death due to neuroinflammation.
Current therapeutic strategies have limitations in fully addressing post-stroke damage.
Targeting inflammatory pathways presents a promising avenue for stroke treatment.

Purpose of the Study:

To review the therapeutic potential of major histocompatibility complex (MHC) Class II constructs for ischemic stroke.
To highlight the efficacy of the MHC Class II construct, DRmQ, in preclinical models.
To discuss the anti-inflammatory mechanisms underlying DRmQ's neuroprotective effects.

Main Methods:

Review of existing literature on MHC Class II constructs and stroke.
Analysis of studies investigating DRmQ's effects on behavioral deficits and neuroinflammation.
Comparison with other anti-neuroinflammation strategies like stem cell and mitochondrial transplantation.

Main Results:

DRmQ demonstrated significant attenuation of behavioral deficits in stroke models.
DRmQ treatment decreased microglia activation and reduced proinflammatory cytokine levels.
These findings suggest DRmQ mitigates secondary cell death following ischemic stroke.

Conclusions:

MHC Class II constructs, particularly DRmQ, represent a viable therapeutic strategy for ischemic stroke.
The anti-inflammatory action of DRmQ is key to its neuroprotective benefits.
Inflammation sequestration is a robust therapeutic target for mitigating stroke-induced damage.